- call +1-201-465-4211
- email sales@marketsandresearch.biz
- Call +1-201-465-4211
- Email: sales@marketsandresearch.biz
According to this study, over the next five years the Osteoarthritis Pain Drugs market will register a 5.9%% CAGR in terms of revenue, the global market size will reach $ 10220 million by 2025, from $ 8115 million in 2019. In particular, this report presents the global market share (sales and revenue) of key companies in Osteoarthritis Pain Drugs business, shared in Chapter 3.
This report presents a comprehensive overview, market shares, and growth opportunities of Osteoarthritis Pain Drugs market by product type, application, key manufacturers and key regions and countries.
This study specially analyses the impact of Covid-19 outbreak on the Osteoarthritis Pain Drugs, covering the supply chain analysis, impact assessment to the Osteoarthritis Pain Drugs market size growth rate in several scenarios, and the measures to be undertaken by Osteoarthritis Pain Drugs companies in response to the COVID-19 epidemic.
Segmentation by type: breakdown data from 2015 to 2020, in Section 2.3; and forecast to 2025 in section 11.7.
Oral
Injection
External
Segmentation by application: breakdown data from 2015 to 2020, in Section 2.4; and forecast to 2024 in section 11.8.
Medical Care
Personal Care
This report also splits the market by region: Breakdown data in Chapter 4, 5, 6, 7 and 8.
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
The report also presents the market competition landscape and a corresponding detailed analysis of the major vendor/manufacturers in the market. The key manufacturers covered in this report: Breakdown data in in Chapter 3.
Sino Biopharmaceutical
Freda
Chugai Pharmaceutical
Mikasa Seiyaku
Bayer
Pfizer
Taisho Pharmaceutical
Haohai Biological
Zhejiang Chengyi Pharmaceutical
SK Chemicals
Crystal Genomics
GlaxoSmithKline
Johnson & Johnson
Bright Future
GSK
Seikagaku Corporation
Lilly
Sanofi
Jingfeng Pharmaceutical
Mylan
Almatica Pharma
TEVA
Abbott Laboratories
Iroko Pharmaceuticals
In addition, this report discusses the key drivers influencing market growth, opportunities, the challenges and the risks faced by key manufacturers and the market as a whole. It also analyzes key emerging trends and their impact on present and future development.
Research objectives
To study and analyze the global Osteoarthritis Pain Drugs consumption (value & volume) by key regions/countries, type and application, history data from 2015 to 2019, and forecast to 2025.
To understand the structure of Osteoarthritis Pain Drugs market by identifying its various subsegments.
Focuses on the key global Osteoarthritis Pain Drugs manufacturers, to define, describe and analyze the sales volume, value, market share, market competition landscape, SWOT analysis and development plans in next few years.
To analyze the Osteoarthritis Pain Drugs with respect to individual growth trends, future prospects, and their contribution to the total market.
To share detailed information about the key factors influencing the growth of the market (growth potential, opportunities, drivers, industry-specific challenges and risks).
To project the consumption of Osteoarthritis Pain Drugs submarkets, with respect to key regions (along with their respective key countries).
To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
To strategically profile the key players and comprehensively analyze their growth strategies.
The base year for the study has been considered 2019, historic year 2014 and 2018, the forecast period considered is from 2020 to 2027. The regions analyzed for the market include North America, Europe, South America, Asia Pacific, and Middle East and Africa. These regions are further analyzed at the country-level. The study also includes attractiveness analysis of type, application and regions which are benchmarked based on their market size, growth rate and attractiveness in terms of present and future opportunity for understanding the future growth of the market.
Market is segmented on the basis:
The report offers in-depth analysis of driving factors, opportunities, restraints, and challenges for gaining the key insight of the market. The report emphasizes on all the key trends that play a vital role in the enlargement of the market from 2019 to 2026.
The report provides company profile of the key players operating in the market and a comparative analysis based on their business overviews industry offering, segment market share, regional presence, business strategies, innovations, mergers & acquisitions, recent developments, joint venture, collaborations, partnerships, SWOT analysis, and key financial information.
1 Scope of the Report
1.1 Market Introduction
1.2 Research Objectives
1.3 Years Considered
1.4 Market Research Methodology
1.5 Data Source
1.6 Economic Indicators
1.7 Currency Considered
2 Executive Summary
2.1 World Market Overview
2.1.1 Global Osteoarthritis Pain Drugs Consumption 2015-2025
2.1.2 Osteoarthritis Pain Drugs Consumption CAGR by Region
2.2 Osteoarthritis Pain Drugs Segment by Type
2.2.1 Oral
2.2.2 Injection
2.2.3 External
2.3 Osteoarthritis Pain Drugs Consumption by Type
2.3.1 Global Osteoarthritis Pain Drugs Consumption Market Share by Type (2015-2020)
2.3.2 Global Osteoarthritis Pain Drugs Revenue and Market Share by Type (2015-2020)
2.3.3 Global Osteoarthritis Pain Drugs Sale Price by Type (2015-2020)
2.4 Osteoarthritis Pain Drugs Segment by Application
2.4.1 Medical Care
2.4.2 Personal Care
2.5 Osteoarthritis Pain Drugs Consumption by Application
2.5.1 Global Osteoarthritis Pain Drugs Consumption Market Share by Type (2015-2020)
2.5.2 Global Osteoarthritis Pain Drugs Value and Market Share by Type (2015-2020)
2.5.3 Global Osteoarthritis Pain Drugs Sale Price by Type (2015-2020)
3 Global Osteoarthritis Pain Drugs by Company
3.1 Global Osteoarthritis Pain Drugs Sales Market Share by Company
3.1.1 Global Osteoarthritis Pain Drugs Sales by Company (2018-2020)
3.1.2 Global Osteoarthritis Pain Drugs Sales Market Share by Company (2018-2020)
3.2 Global Osteoarthritis Pain Drugs Revenue Market Share by Company
3.2.1 Global Osteoarthritis Pain Drugs Revenue by Company (2018-2020)
3.2.2 Global Osteoarthritis Pain Drugs Revenue Market Share by Company (2018-2020)
3.3 Global Osteoarthritis Pain Drugs Sale Price by Company
3.4 Global Osteoarthritis Pain Drugs Manufacturing Base Distribution, Sales Area, Type by Company
3.4.1 Global Osteoarthritis Pain Drugs Manufacturing Base Distribution and Sales Area by Company
3.4.2 Players Osteoarthritis Pain Drugs Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) (2018-2020)
3.6 New Products and Potential Entrants
3.7 Mergers & Acquisitions, Expansion
4 Osteoarthritis Pain Drugs by Regions
4.1 Osteoarthritis Pain Drugs by Regions
4.2 Americas Osteoarthritis Pain Drugs Consumption Growth
4.3 APAC Osteoarthritis Pain Drugs Consumption Growth
4.4 Europe Osteoarthritis Pain Drugs Consumption Growth
4.5 Middle East & Africa Osteoarthritis Pain Drugs Consumption Growth
5 Americas
5.1 Americas Osteoarthritis Pain Drugs Consumption by Countries
5.1.1 Americas Osteoarthritis Pain Drugs Consumption by Countries (2015-2020)
5.1.2 Americas Osteoarthritis Pain Drugs Value by Countries (2015-2020)
5.2 Americas Osteoarthritis Pain Drugs Consumption by Type
5.3 Americas Osteoarthritis Pain Drugs Consumption by Application
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
5.8 Key Economic Indicators of Few Americas Countries
6 APAC
6.1 APAC Osteoarthritis Pain Drugs Consumption by Regions
6.1.1 APAC Osteoarthritis Pain Drugs Consumption by Regions (2015-2020)
6.1.2 APAC Osteoarthritis Pain Drugs Value by Regions (2015-2020)
6.2 APAC Osteoarthritis Pain Drugs Consumption by Type
6.3 APAC Osteoarthritis Pain Drugs Consumption by Application
6.4 China
6.5 Japan
6.6 Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 Key Economic Indicators of Few APAC Regions
7 Europe
7.1 Europe Osteoarthritis Pain Drugs by Countries
7.1.1 Europe Osteoarthritis Pain Drugs Consumption by Countries (2015-2020)
7.1.2 Europe Osteoarthritis Pain Drugs Value by Countries (2015-2020)
7.2 Europe Osteoarthritis Pain Drugs Consumption by Type
7.3 Europe Osteoarthritis Pain Drugs Consumption by Application
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
7.9 Key Economic Indicators of Few Europe Countries
8 Middle East & Africa
8.1 Middle East & Africa Osteoarthritis Pain Drugs by Countries
8.1.1 Middle East & Africa Osteoarthritis Pain Drugs Consumption by Countries (2015-2020)
8.1.2 Middle East & Africa Osteoarthritis Pain Drugs Value by Countries (2015-2020)
8.2 Middle East & Africa Osteoarthritis Pain Drugs Consumption by Type
8.3 Middle East & Africa Osteoarthritis Pain Drugs Consumption by Application
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 Market Drivers, Challenges and Trends
9.1 Market Drivers and Impact
9.1.1 Growing Demand from Key Regions
9.1.2 Growing Demand from Key Applications and Potential Industries
9.2 Market Challenges and Impact
9.3 Market Trends
10 Marketing, Distributors and Customer
10.1 Sales Channel
10.1.1 Direct Channels
10.1.2 Indirect Channels
10.2 Osteoarthritis Pain Drugs Distributors
10.3 Osteoarthritis Pain Drugs Customer
11 Global Osteoarthritis Pain Drugs Market Forecast
11.1 Global Osteoarthritis Pain Drugs Consumption Forecast (2021-2025)
11.2 Global Osteoarthritis Pain Drugs Forecast by Regions
11.2.1 Global Osteoarthritis Pain Drugs Forecast by Regions (2021-2025)
11.2.2 Global Osteoarthritis Pain Drugs Value Forecast by Regions (2021-2025)
11.2.3 Americas Consumption Forecast
11.2.4 APAC Consumption Forecast
11.2.5 Europe Consumption Forecast
11.2.6 Middle East & Africa Consumption Forecast
11.3 Americas Forecast by Countries
11.3.1 United States Market Forecast
11.3.2 Canada Market Forecast
11.3.3 Mexico Market Forecast
11.3.4 Brazil Market Forecast
11.4 APAC Forecast byRegions
11.4.1 China Market Forecast
11.4.2 Japan Market Forecast
11.4.3 Korea Market Forecast
11.4.4 Southeast Asia Market Forecast
11.4.5 India Market Forecast
11.4.6 Australia Market Forecast
11.5 Europe Forecast by Countries
11.5.1 Germany Market Forecast
11.5.2 France Market Forecast
11.5.3 UK Market Forecast
11.5.4 Italy Market Forecast
11.5.5 Russia Market Forecast
11.6 Middle East & Africa Forecast by Countries
11.6.1 Egypt Market Forecast
11.6.2 South Africa Market Forecast
11.6.3 Israel Market Forecast
11.6.4 Turkey Market Forecast
11.6.5 GCC Countries Market Forecast
11.7 Global Osteoarthritis Pain Drugs Forecast by Type
11.8 Global Osteoarthritis Pain Drugs Forecast by Application
12 Key Players Analysis
12.1 Sino Biopharmaceutical
12.1.1 Company Information
12.1.2 Osteoarthritis Pain Drugs Product Offered
12.1.3 Sino Biopharmaceutical Osteoarthritis Pain Drugs Sales, Revenue, Price and Gross Margin (2018-2020)
12.1.4 Main Business Overview
12.1.5 Sino Biopharmaceutical Latest Developments
12.2 Freda
12.2.1 Company Information
12.2.2 Osteoarthritis Pain Drugs Product Offered
12.2.3 Freda Osteoarthritis Pain Drugs Sales, Revenue, Price and Gross Margin (2018-2020)
12.2.4 Main Business Overview
12.2.5 Freda Latest Developments
12.3 Chugai Pharmaceutical
12.3.1 Company Information
12.3.2 Osteoarthritis Pain Drugs Product Offered
12.3.3 Chugai Pharmaceutical Osteoarthritis Pain Drugs Sales, Revenue, Price and Gross Margin (2018-2020)
12.3.4 Main Business Overview
12.3.5 Chugai Pharmaceutical Latest Developments
12.4 Mikasa Seiyaku
12.4.1 Company Information
12.4.2 Osteoarthritis Pain Drugs Product Offered
12.4.3 Mikasa Seiyaku Osteoarthritis Pain Drugs Sales, Revenue, Price and Gross Margin (2018-2020)
12.4.4 Main Business Overview
12.4.5 Mikasa Seiyaku Latest Developments
12.5 Bayer
12.5.1 Company Information
12.5.2 Osteoarthritis Pain Drugs Product Offered
12.5.3 Bayer Osteoarthritis Pain Drugs Sales, Revenue, Price and Gross Margin (2018-2020)
12.5.4 Main Business Overview
12.5.5 Bayer Latest Developments
12.6 Pfizer
12.6.1 Company Information
12.6.2 Osteoarthritis Pain Drugs Product Offered
12.6.3 Pfizer Osteoarthritis Pain Drugs Sales, Revenue, Price and Gross Margin (2018-2020)
12.6.4 Main Business Overview
12.6.5 Pfizer Latest Developments
12.7 Taisho Pharmaceutical
12.7.1 Company Information
12.7.2 Osteoarthritis Pain Drugs Product Offered
12.7.3 Taisho Pharmaceutical Osteoarthritis Pain Drugs Sales, Revenue, Price and Gross Margin (2018-2020)
12.7.4 Main Business Overview
12.7.5 Taisho Pharmaceutical Latest Developments
12.8 Haohai Biological
12.8.1 Company Information
12.8.2 Osteoarthritis Pain Drugs Product Offered
12.8.3 Haohai Biological Osteoarthritis Pain Drugs Sales, Revenue, Price and Gross Margin (2018-2020)
12.8.4 Main Business Overview
12.8.5 Haohai Biological Latest Developments
12.9 Zhejiang Chengyi Pharmaceutical
12.9.1 Company Information
12.9.2 Osteoarthritis Pain Drugs Product Offered
12.9.3 Zhejiang Chengyi Pharmaceutical Osteoarthritis Pain Drugs Sales, Revenue, Price and Gross Margin (2018-2020)
12.9.4 Main Business Overview
12.9.5 Zhejiang Chengyi Pharmaceutical Latest Developments
12.10 SK Chemicals
12.10.1 Company Information
12.10.2 Osteoarthritis Pain Drugs Product Offered
12.10.3 SK Chemicals Osteoarthritis Pain Drugs Sales, Revenue, Price and Gross Margin (2018-2020)
12.10.4 Main Business Overview
12.10.5 SK Chemicals Latest Developments
12.11 Crystal Genomics
12.11.1 Company Information
12.11.2 Osteoarthritis Pain Drugs Product Offered
12.11.3 Crystal Genomics Osteoarthritis Pain Drugs Sales, Revenue, Price and Gross Margin (2018-2020)
12.11.4 Main Business Overview
12.11.5 Crystal Genomics Latest Developments
12.12 GlaxoSmithKline
12.12.1 Company Information
12.12.2 Osteoarthritis Pain Drugs Product Offered
12.12.3 GlaxoSmithKline Osteoarthritis Pain Drugs Sales, Revenue, Price and Gross Margin (2018-2020)
12.12.4 Main Business Overview
12.12.5 GlaxoSmithKline Latest Developments
12.13 Johnson & Johnson
12.13.1 Company Information
12.13.2 Osteoarthritis Pain Drugs Product Offered
12.13.3 Johnson & Johnson Osteoarthritis Pain Drugs Sales, Revenue, Price and Gross Margin (2018-2020)
12.13.4 Main Business Overview
12.13.5 Johnson & Johnson Latest Developments
12.14 Bright Future
12.14.1 Company Information
12.14.2 Osteoarthritis Pain Drugs Product Offered
12.14.3 Bright Future Osteoarthritis Pain Drugs Sales, Revenue, Price and Gross Margin (2018-2020)
12.14.4 Main Business Overview
12.14.5 Bright Future Latest Developments
12.15 GSK
12.15.1 Company Information
12.15.2 Osteoarthritis Pain Drugs Product Offered
12.15.3 GSK Osteoarthritis Pain Drugs Sales, Revenue, Price and Gross Margin (2018-2020)
12.15.4 Main Business Overview
12.15.5 GSK Latest Developments
12.16 Seikagaku Corporation
12.16.1 Company Information
12.16.2 Osteoarthritis Pain Drugs Product Offered
12.16.3 Seikagaku Corporation Osteoarthritis Pain Drugs Sales, Revenue, Price and Gross Margin (2018-2020)
12.16.4 Main Business Overview
12.16.5 Seikagaku Corporation Latest Developments
12.17 Lilly
12.17.1 Company Information
12.17.2 Osteoarthritis Pain Drugs Product Offered
12.17.3 Lilly Osteoarthritis Pain Drugs Sales, Revenue, Price and Gross Margin (2018-2020)
12.17.4 Main Business Overview
12.17.5 Lilly Latest Developments
12.18 Sanofi
12.18.1 Company Information
12.18.2 Osteoarthritis Pain Drugs Product Offered
12.18.3 Sanofi Osteoarthritis Pain Drugs Sales, Revenue, Price and Gross Margin (2018-2020)
12.18.4 Main Business Overview
12.18.5 Sanofi Latest Developments
12.19 Jingfeng Pharmaceutical
12.19.1 Company Information
12.19.2 Osteoarthritis Pain Drugs Product Offered
12.19.3 Jingfeng Pharmaceutical Osteoarthritis Pain Drugs Sales, Revenue, Price and Gross Margin (2018-2020)
12.19.4 Main Business Overview
12.19.5 Jingfeng Pharmaceutical Latest Developments
12.20 Mylan
12.20.1 Company Information
12.20.2 Osteoarthritis Pain Drugs Product Offered
12.20.3 Mylan Osteoarthritis Pain Drugs Sales, Revenue, Price and Gross Margin (2018-2020)
12.20.4 Main Business Overview
12.20.5 Mylan Latest Developments
12.21 Almatica Pharma
12.21.1 Company Information
12.21.2 Osteoarthritis Pain Drugs Product Offered
12.21.3 Almatica Pharma Osteoarthritis Pain Drugs Sales, Revenue, Price and Gross Margin (2018-2020)
12.21.4 Main Business Overview
12.21.5 Almatica Pharma Latest Developments
12.22 TEVA
12.22.1 Company Information
12.22.2 Osteoarthritis Pain Drugs Product Offered
12.22.3 TEVA Osteoarthritis Pain Drugs Sales, Revenue, Price and Gross Margin (2018-2020)
12.22.4 Main Business Overview
12.22.5 TEVA Latest Developments
12.23 Abbott Laboratories
12.23.1 Company Information
12.23.2 Osteoarthritis Pain Drugs Product Offered
12.23.3 Abbott Laboratories Osteoarthritis Pain Drugs Sales, Revenue, Price and Gross Margin (2018-2020)
12.23.4 Main Business Overview
12.23.5 Abbott Laboratories Latest Developments
12.24 Iroko Pharmaceuticals
12.24.1 Company Information
12.24.2 Osteoarthritis Pain Drugs Product Offered
12.24.3 Iroko Pharmaceuticals Osteoarthritis Pain Drugs Sales, Revenue, Price and Gross Margin (2018-2020)
12.24.4 Main Business Overview
12.24.5 Iroko Pharmaceuticals Latest Developments
13 Research Findings and Conclusion
List of Tables
Table 1. Research Methodology
Table 2. Data Source
Table 3. Osteoarthritis Pain Drugs Consumption CAGR by Region 2015-2025 ($ Millions)
Table 4. Major Players of Oral
Table 5. Major Players of Injection
Table 6. Major Players of External
Table 7. Global Consumption Sales by Type (2015-2020)
Table 8. Global Osteoarthritis Pain Drugs Consumption Market Share by Type (2015-2020)
Table 9. Global Osteoarthritis Pain Drugs Revenue by Type (2015-2020) ($ million)
Table 10. Global Osteoarthritis Pain Drugs Value Market Share by Type (2015-2020) ($ Millions)
Table 11. Global Osteoarthritis Pain Drugs Sale Price by Type (2015-2020)
Table 12. Global Consumption Sales by Application (2015-2020)
Table 13. Global Osteoarthritis Pain Drugs Consumption Market Share by Application (2015-2020)
Table 14. Global Osteoarthritis Pain Drugs Value by Application (2015-2020)
Table 15. Global Osteoarthritis Pain Drugs Value Market Share by Application (2015-2020)
Table 16. Global Osteoarthritis Pain Drugs Sale Price by Application (2015-2020)
Table 17. Global Osteoarthritis Pain Drugs Sales by Company (2017-2019) (M Dose)
Table 18. Global Osteoarthritis Pain Drugs Sales Market Share by Company (2017-2019)
Table 19. Global Osteoarthritis Pain Drugs Revenue by Company (2017-2019) ($ Millions)
Table 20. Global Osteoarthritis Pain Drugs Revenue Market Share by Company (2017-2019)
Table 21. Global Osteoarthritis Pain Drugs Sale Price by Company (2017-2019)
Table 22. Global Osteoarthritis Pain Drugs Manufacturing Base Distribution and Sales Area by Manufacturers
Table 23. Players Osteoarthritis Pain Drugs Products Offered
Table 24. Osteoarthritis Pain Drugs Concentration Ratio (CR3, CR5 and CR10) (2017-2019)
Table 25. Global Osteoarthritis Pain Drugs Consumption by Regions 2015-2020 (M Dose)
Table 26. Global Osteoarthritis Pain Drugs Consumption Market Share by Regions 2015-2020
Table 27. Global Osteoarthritis Pain Drugs Value by Regions 2015-2020 ($ Millions)
Table 28. Global Osteoarthritis Pain Drugs Value Market Share by Regions 2015-2020
Table 29. Americas Osteoarthritis Pain Drugs Consumption by Countries (2015-2020) (M Dose)
Table 30. Americas Osteoarthritis Pain Drugs Consumption Market Share by Countries (2015-2020)
Table 31. Americas Osteoarthritis Pain Drugs Value by Countries (2015-2020) ($ Millions)
Table 32. Americas Osteoarthritis Pain Drugs Value Market Share by Countries (2015-2020)
Table 33. Americas Osteoarthritis Pain Drugs Consumption by Type (2015-2020) (M Dose)
Table 34. Americas Osteoarthritis Pain Drugs Consumption Market Share by Type (2015-2020)
Table 35. Americas Osteoarthritis Pain Drugs Consumption by Application (2015-2020) (M Dose)
Table 36. Americas Osteoarthritis Pain Drugs Consumption Market Share by Application (2015-2020)
Table 37. APAC Osteoarthritis Pain Drugs Consumption by Regions (2015-2020) (M Dose)
Table 38. APAC Osteoarthritis Pain Drugs Consumption Market Share by Regions (2015-2020)
Table 39. APAC Osteoarthritis Pain Drugs Value by Regions (2015-2020) ($ Millions)
Table 40. APAC Osteoarthritis Pain Drugs Value Market Share by Regions (2015-2020)
Table 41. APAC Osteoarthritis Pain Drugs Consumption by Type (2015-2020) (M Dose)
Table 42. APAC Osteoarthritis Pain Drugs Consumption Market Share by Type (2015-2020)
Table 43. APAC Osteoarthritis Pain Drugs Consumption by Application (2015-2020) (M Dose)
Table 44. APAC Osteoarthritis Pain Drugs Consumption Market Share by Application (2015-2020)
Table 45. Europe Osteoarthritis Pain Drugs Consumption by Countries (2015-2020) (M Dose)
Table 46. Europe Osteoarthritis Pain Drugs Consumption Market Share by Countries (2015-2020)
Table 47. Europe Osteoarthritis Pain Drugs Value by Countries (2015-2020) ($ Millions)
Table 48. Europe Osteoarthritis Pain Drugs Value Market Share by Countries (2015-2020)
Table 49. Europe Osteoarthritis Pain Drugs Consumption by Type (2015-2020) (M Dose)
Table 50. Europe Osteoarthritis Pain Drugs Consumption Market Share by Type (2015-2020)
Table 51. Europe Osteoarthritis Pain Drugs Consumption by Application (2015-2020) (M Dose)
Table 52. Europe Osteoarthritis Pain Drugs Consumption Market Share by Application (2015-2020)
Table 53. Middle East & Africa Osteoarthritis Pain Drugs Consumption by Countries (2015-2020) (M Dose)
Table 54. Middle East & Africa Osteoarthritis Pain Drugs Consumption Market Share by Countries (2015-2020)
Table 55. Middle East & Africa Osteoarthritis Pain Drugs Value by Countries (2015-2020) ($ Millions)
Table 56. Middle East & Africa Osteoarthritis Pain Drugs Value Market Share by Countries (2015-2020)
Table 57. Middle East & Africa Osteoarthritis Pain Drugs Consumption by Type (2015-2020) (M Dose)
Table 58. Middle East & Africa Osteoarthritis Pain Drugs Consumption Market Share by Type (2015-2020)
Table 59. Middle East & Africa Osteoarthritis Pain Drugs Consumption by Application (2015-2020) (M Dose)
Table 60. Middle East & Africa Osteoarthritis Pain Drugs Consumption Market Share by Application (2015-2020)
Table 61. Osteoarthritis Pain Drugs Distributors List
Table 62. Osteoarthritis Pain Drugs Customer List
Table 63. Global Osteoarthritis Pain Drugs Consumption Forecast by Countries (2021-2025) (M Dose)
Table 64. Global Osteoarthritis Pain Drugs Consumption Market Forecast by Regions
Table 65. Global Osteoarthritis Pain Drugs Value Forecast by Countries (2021-2025) ($ Millions)
Table 66. Global Osteoarthritis Pain Drugs Value Market Share Forecast by Regions
Table 67. Global Osteoarthritis Pain Drugs Consumption Forecast by Type (2021-2025) (M Dose)
Table 68. Global Osteoarthritis Pain Drugs Consumption Market Share Forecast by Type (2021-2025)
Table 69. Global Osteoarthritis Pain Drugs Value Forecast by Type (2021-2025) ($ Millions)
Table 70. Global Osteoarthritis Pain Drugs Value Market Share Forecast by Type (2021-2025)
Table 71. Global Osteoarthritis Pain Drugs Consumption Forecast by Application (2021-2025) (M Dose)
Table 72. Global Osteoarthritis Pain Drugs Consumption Market Share Forecast by Application (2021-2025)
Table 73. Global Osteoarthritis Pain Drugs Value Forecast by Application (2021-2025) ($ Millions)
Table 74. Global Osteoarthritis Pain Drugs Value Market Share Forecast by Application (2021-2025)
Table 75. Sino Biopharmaceutical Product Offered
Table 76. Sino Biopharmaceutical Osteoarthritis Pain Drugs Sales (M Dose), Revenue ($ Million), Price (USD/Dose) and Gross Margin (2018-2020E)
Table 77. Sino Biopharmaceutical Main Business
Table 78. Sino Biopharmaceutical Latest Developments
Table 79. Sino Biopharmaceutical Basic Information, Company Total Revenue (in $ million), Osteoarthritis Pain Drugs Manufacturing Base, Sales Area and Its Competitors
Table 80. Freda Product Offered
Table 81. Freda Osteoarthritis Pain Drugs Sales (M Dose), Revenue ($ Million), Price (USD/Dose) and Gross Margin (2018-2020E)
Table 82. Freda Main Business
Table 83. Freda Latest Developments
Table 84. Freda Basic Information, Company Total Revenue (in $ million), Osteoarthritis Pain Drugs Manufacturing Base, Sales Area and Its Competitors
Table 85. Chugai Pharmaceutical Product Offered
Table 86. Chugai Pharmaceutical Osteoarthritis Pain Drugs Sales (M Dose), Revenue ($ Million), Price (USD/Dose) and Gross Margin (2018-2020E)
Table 87. Chugai Pharmaceutical Main Business
Table 88. Chugai Pharmaceutical Latest Developments
Table 89. Chugai Pharmaceutical Basic Information, Company Total Revenue (in $ million), Osteoarthritis Pain Drugs Manufacturing Base, Sales Area and Its Competitors
Table 90. Mikasa Seiyaku Product Offered
Table 91. Mikasa Seiyaku Osteoarthritis Pain Drugs Sales (M Dose), Revenue ($ Million), Price (USD/Dose) and Gross Margin (2018-2020E)
Table 92. Mikasa Seiyaku Main Business
Table 93. Mikasa Seiyaku Latest Developments
Table 94. Mikasa Seiyaku Basic Information, Company Total Revenue (in $ million), Osteoarthritis Pain Drugs Manufacturing Base, Sales Area and Its Competitors
Table 95. Bayer Product Offered
Table 96. Bayer Osteoarthritis Pain Drugs Sales (M Dose), Revenue ($ Million), Price (USD/Dose) and Gross Margin (2018-2020E)
Table 97. Bayer Main Business
Table 98. Bayer Latest Developments
Table 99. Bayer Basic Information, Company Total Revenue (in $ million), Osteoarthritis Pain Drugs Manufacturing Base, Sales Area and Its Competitors
Table 100. Pfizer Product Offered
Table 101. Pfizer Osteoarthritis Pain Drugs Sales (M Dose), Revenue ($ Million), Price (USD/Dose) and Gross Margin (2018-2020E)
Table 102. Pfizer Main Business
Table 103. Pfizer Latest Developments
Table 104. Pfizer Basic Information, Company Total Revenue (in $ million), Osteoarthritis Pain Drugs Manufacturing Base, Sales Area and Its Competitors
Table 105. Taisho Pharmaceutical Product Offered
Table 106. Taisho Pharmaceutical Basic Information, Company Total Revenue (in $ million), Osteoarthritis Pain Drugs Manufacturing Base, Sales Area and Its Competitors
Table 107. Taisho Pharmaceutical Main Business
Table 108. Taisho Pharmaceutical Latest Developments
Table 109. Taisho Pharmaceutical Osteoarthritis Pain Drugs Sales (M Dose), Revenue ($ Million), Price (USD/Dose) and Gross Margin (2018-2020E)
Table 110. Haohai Biological Product Offered
Table 111. Haohai Biological Osteoarthritis Pain Drugs Sales (M Dose), Revenue ($ Million), Price (USD/Dose) and Gross Margin (2018-2020E)
Table 112. Haohai Biological Main Business
Table 113. Haohai Biological Latest Developments
Table 114. Haohai Biological Basic Information, Company Total Revenue (in $ million), Osteoarthritis Pain Drugs Manufacturing Base, Sales Area and Its Competitors
Table 115. Zhejiang Chengyi Pharmaceutical Product Offered
Table 116. Zhejiang Chengyi Pharmaceutical Osteoarthritis Pain Drugs Sales (M Dose), Revenue ($ Million), Price (USD/Dose) and Gross Margin (2018-2020E)
Table 117. Zhejiang Chengyi Pharmaceutical Main Business
Table 118. Zhejiang Chengyi Pharmaceutical Latest Developments
Table 119. Zhejiang Chengyi Pharmaceutical Basic Information, Company Total Revenue (in $ million), Osteoarthritis Pain Drugs Manufacturing Base, Sales Area and Its Competitors
Table 120. SK Chemicals Product Offered
Table 121. SK Chemicals Osteoarthritis Pain Drugs Sales (M Dose), Revenue ($ Million), Price (USD/Dose) and Gross Margin (2018-2020E)
Table 122. SK Chemicals Main Business
Table 123. SK Chemicals Latest Developments
Table 124. SK Chemicals Basic Information, Company Total Revenue (in $ million), Osteoarthritis Pain Drugs Manufacturing Base, Sales Area and Its Competitors
Table 125. Crystal Genomics Product Offered
Table 126. Crystal Genomics Osteoarthritis Pain Drugs Sales (M Dose), Revenue ($ Million), Price (USD/Dose) and Gross Margin (2018-2020E)
Table 127. Crystal Genomics Main Business
Table 128. Crystal Genomics Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table 129. Crystal Genomics Latest Developments
Table 130. GlaxoSmithKline Product Offered
Table 131. GlaxoSmithKline Osteoarthritis Pain Drugs Sales (M Dose), Revenue ($ Million), Price (USD/Dose) and Gross Margin (2018-2020E)
Table 132. GlaxoSmithKline Main Business
Table 133. GlaxoSmithKline Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table 134. GlaxoSmithKline Latest Developments
Table 135. Johnson & Johnson Product Offered
Table 136. Johnson & Johnson Osteoarthritis Pain Drugs Sales (M Dose), Revenue ($ Million), Price (USD/Dose) and Gross Margin (2018-2020E)
Table 137. Johnson & Johnson Main Business
Table 138. Johnson & Johnson Latest Developments
Table 139. Johnson & Johnson Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table 140. Bright Future Product Offered
Table 141. Bright Future Osteoarthritis Pain Drugs Sales (M Dose), Revenue ($ Million), Price (USD/Dose) and Gross Margin (2018-2020E)
Table 142. Bright Future Main Business
Table 143. Bright Future Latest Developments
Table 144. Bright Future Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table 145. GSK Product Offered
Table 146. GSK Osteoarthritis Pain Drugs Sales (M Dose), Revenue ($ Million), Price (USD/Dose) and Gross Margin (2018-2020E)
Table 147. GSK Main Business
Table 148. GSK Latest Developments
Table 149. GSK Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table 150. Seikagaku Corporation Product Offered
Table 151. Seikagaku Corporation Osteoarthritis Pain Drugs Sales (M Dose), Revenue ($ Million), Price (USD/Dose) and Gross Margin (2018-2020E)
Table 152. Seikagaku Corporation Main Business
Table 153. Seikagaku Corporation Latest Developments
Table 154. Seikagaku Corporation Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table 155. Lilly Product Offered
Table 156. Lilly Osteoarthritis Pain Drugs Sales (M Dose), Revenue ($ Million), Price (USD/Dose) and Gross Margin (2018-2020E)
Table 157. Lilly Main Business
Table 158. Lilly Latest Developments
Table 159. Lilly Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table 160. Sanofi Product Offered
Table 161. Sanofi Osteoarthritis Pain Drugs Sales (M Dose), Revenue ($ Million), Price (USD/Dose) and Gross Margin (2018-2020E)
Table 162. Sanofi Main Business
Table 163. Sanofi Latest Developments
Table 164. Sanofi Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table 165. Jingfeng Pharmaceutical Product Offered
Table 166. Jingfeng Pharmaceutical Osteoarthritis Pain Drugs Sales (M Dose), Revenue ($ Million), Price (USD/Dose) and Gross Margin (2018-2020E)
Table 167. Jingfeng Pharmaceutical Main Business
Table 168. Jingfeng Pharmaceutical Latest Developments
Table 169. Jingfeng Pharmaceutical Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table 170. Mylan Product Offered
Table 171. Mylan Osteoarthritis Pain Drugs Sales (M Dose), Revenue ($ Million), Price (USD/Dose) and Gross Margin (2018-2020E)
Table 172. Mylan Main Business
Table 173. Mylan Latest Developments
Table 174. Mylan Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table 175. Almatica Pharma Product Offered
Table 176. Almatica Pharma Osteoarthritis Pain Drugs Sales (M Dose), Revenue ($ Million), Price (USD/Dose) and Gross Margin (2018-2020E)
Table 177. Almatica Pharma Main Business
Table 178. Almatica Pharma Latest Developments
Table 179. Almatica Pharma Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table 180. TEVA Product Offered
Table 181. TEVA Osteoarthritis Pain Drugs Sales (M Dose), Revenue ($ Million), Price (USD/Dose) and Gross Margin (2018-2020E)
Table 182. TEVA Main Business
Table 183. TEVA Latest Developments
Table 184. TEVA Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table 185. Abbott Laboratories Product Offered
Table 186. Abbott Laboratories Osteoarthritis Pain Drugs Sales (M Dose), Revenue ($ Million), Price (USD/Dose) and Gross Margin (2018-2020E)
Table 187. Abbott Laboratories Main Business
Table 188. Abbott Laboratories Latest Developments
Table 189. Abbott Laboratories Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table 190. Iroko Pharmaceuticals Product Offered
Table 191. Iroko Pharmaceuticals Osteoarthritis Pain Drugs Sales (M Dose), Revenue ($ Million), Price (USD/Dose) and Gross Margin (2018-2020E)
Table 192. Iroko Pharmaceuticals Main Business
Table 193. Iroko Pharmaceuticals Latest Developments
Table 194. Iroko Pharmaceuticals Basic Information, Manufacturing Base, Sales Area and Its Competitors
List of Figures
Figure 1. Picture of Osteoarthritis Pain Drugs
Figure 2. Osteoarthritis Pain Drugs Report Years Considered
Figure 3. Market Research Methodology
Figure 4. Global Osteoarthritis Pain Drugs Consumption Growth Rate 2015-2025 (M Dose)
Figure 5. Global Osteoarthritis Pain Drugs Value Growth Rate 2015-2025 ($ Millions)
Figure 6. Product Picture of Oral
Figure 7. Product Picture of Injection
Figure 8. Product Picture of External
Figure 9. Global Osteoarthritis Pain Drugs Consumption Market Share by Type (2015-2020)
Figure 10. Global Osteoarthritis Pain Drugs Value Market Share by Type (2015-2020)
Figure 11. Osteoarthritis Pain Drugs Consumed in Medical Care
Figure 12. Global Osteoarthritis Pain Drugs Market: Medical Care (2015-2020) (M Dose)
Figure 13. Global Osteoarthritis Pain Drugs Market: Medical Care (2015-2020) ($ Millions)
Figure 14. Osteoarthritis Pain Drugs Consumed in Personal Care
Figure 15. Global Osteoarthritis Pain Drugs Market: Personal Care (2015-2020) (M Dose)
Figure 16. Global Osteoarthritis Pain Drugs Market: Personal Care (2015-2020) ($ Millions)
Figure 17. Global Osteoarthritis Pain Drugs Consumption Market Share by Application (2015-2020)
Figure 18. Global Osteoarthritis Pain Drugs Value Market Share by Application (2015-2020)
Figure 19. Global Osteoarthritis Pain Drugs Sales Market Share by Company in 2017
Figure 20. Global Osteoarthritis Pain Drugs Sales Market Share by Company in 2019
Figure 21. Global Osteoarthritis Pain Drugs Revenue Market Share by Company in 2017
Figure 22. Global Osteoarthritis Pain Drugs Revenue Market Share by Company in 2019
Figure 23. Global Osteoarthritis Pain Drugs Sale Price by Company in 2019
Figure 24. Global Osteoarthritis Pain Drugs Consumption Market Share by Regions 2015-2020
Figure 25. Global Osteoarthritis Pain Drugs Value Market Share by Regions 2015-2020
Figure 26. Americas Osteoarthritis Pain Drugs Consumption 2015-2020 (M Dose)
Figure 27. Americas Osteoarthritis Pain Drugs Value 2015-2020 ($ Millions)
Figure 28. APAC Osteoarthritis Pain Drugs Consumption 2015-2020 (M Dose)
Figure 29. APAC Osteoarthritis Pain Drugs Value 2015-2020 ($ Millions)
Figure 30. Europe Osteoarthritis Pain Drugs Consumption 2015-2020 (M Dose)
Figure 31. Europe Osteoarthritis Pain Drugs Value 2015-2020 ($ Millions)
Figure 32. Middle East & Africa Osteoarthritis Pain Drugs Consumption 2015-2020 (M Dose)
Figure 33. Middle East & Africa Osteoarthritis Pain Drugs Value 2015-2020 ($ Millions)
Figure 34. Americas Osteoarthritis Pain Drugs Consumption Market Share by Countries in 2019
Figure 35. Americas Osteoarthritis Pain Drugs Value Market Share by Countries in 2019
Figure 36. Americas Osteoarthritis Pain Drugs Consumption Market Share by Type in 2019
Figure 37. Americas Osteoarthritis Pain Drugs Consumption Market Share by Application in 2019
Figure 38. United States Osteoarthritis Pain Drugs Consumption Growth 2015-2020 (M Dose)
Figure 39. United States Osteoarthritis Pain Drugs Value Growth 2015-2020 ($ Millions)
Figure 40. Canada Osteoarthritis Pain Drugs Consumption Growth 2015-2020 (M Dose)
Figure 41. Canada Osteoarthritis Pain Drugs Value Growth 2015-2020 ($ Millions)
Figure 42. Mexico Osteoarthritis Pain Drugs Consumption Growth 2015-2020 (M Dose)
Figure 43. Mexico Osteoarthritis Pain Drugs Value Growth 2015-2020 ($ Millions)
Figure 44. APAC Osteoarthritis Pain Drugs Consumption Market Share by Countries in 2019
Figure 45. APAC Osteoarthritis Pain Drugs Value Market Share by Regions in 2019
Figure 46. APAC Osteoarthritis Pain Drugs Consumption Market Share by Type in 2019
Figure 47. APAC Osteoarthritis Pain Drugs Consumption Market Share by Application in 2019
Figure 48. China Osteoarthritis Pain Drugs Consumption Growth 2015-2020 (M Dose)
Figure 49. China Osteoarthritis Pain Drugs Value Growth 2015-2020 ($ Millions)
Figure 50. Japan Osteoarthritis Pain Drugs Consumption Growth 2015-2020 (M Dose)
Figure 51. Japan Osteoarthritis Pain Drugs Value Growth 2015-2020 ($ Millions)
Figure 52. Korea Osteoarthritis Pain Drugs Consumption Growth 2015-2020 (M Dose)
Figure 53. Korea Osteoarthritis Pain Drugs Value Growth 2015-2020 ($ Millions)
Figure 54. Southeast Asia Osteoarthritis Pain Drugs Consumption Growth 2015-2020 (M Dose)
Figure 55. Southeast Asia Osteoarthritis Pain Drugs Value Growth 2015-2020 ($ Millions)
Figure 56. India Osteoarthritis Pain Drugs Consumption Growth 2015-2020 (M Dose)
Figure 57. India Osteoarthritis Pain Drugs Value Growth 2015-2020 ($ Millions)
Figure 58. Australia Osteoarthritis Pain Drugs Consumption Growth 2015-2020 (M Dose)
Figure 59. Australia Osteoarthritis Pain Drugs Value Growth 2015-2020 ($ Millions)
Figure 60. Europe Osteoarthritis Pain Drugs Consumption Market Share by Countries in 2019
Figure 61. Europe Osteoarthritis Pain Drugs Value Market Share by Countries in 2019
Figure 62. Europe Osteoarthritis Pain Drugs Consumption Market Share by Type in 2019
Figure 63. Europe Osteoarthritis Pain Drugs Consumption Market Share by Application in 2019
Figure 64. Germany Osteoarthritis Pain Drugs Consumption Growth 2015-2020 (M Dose)
Figure 65. Germany Osteoarthritis Pain Drugs Value Growth 2015-2020 ($ Millions)
Figure 66. France Osteoarthritis Pain Drugs Consumption Growth 2015-2020 (M Dose)
Figure 67. France Osteoarthritis Pain Drugs Value Growth 2015-2020 ($ Millions)
Figure 68. UK Osteoarthritis Pain Drugs Consumption Growth 2015-2020 (M Dose)
Figure 69. UK Osteoarthritis Pain Drugs Value Growth 2015-2020 ($ Millions)
Figure 70. Italy Osteoarthritis Pain Drugs Consumption Growth 2015-2020 (M Dose)
Figure 71. Italy Osteoarthritis Pain Drugs Value Growth 2015-2020 ($ Millions)
Figure 72. Russia Osteoarthritis Pain Drugs Consumption Growth 2015-2020 (M Dose)
Figure 73. Russia Osteoarthritis Pain Drugs Value Growth 2015-2020 ($ Millions)
Figure 74. Middle East & Africa Osteoarthritis Pain Drugs Consumption Market Share by Countries in 2019
Figure 75. Middle East & Africa Osteoarthritis Pain Drugs Value Market Share by Countries in 2019
Figure 76. Middle East & Africa Osteoarthritis Pain Drugs Consumption Market Share by Type in 2019
Figure 77. Middle East & Africa Osteoarthritis Pain Drugs Consumption Market Share by Application in 2019
Figure 78. Egypt Osteoarthritis Pain Drugs Consumption Growth 2015-2020 (M Dose)
Figure 79. Egypt Osteoarthritis Pain Drugs Value Growth 2015-2020 ($ Millions)
Figure 80. South Africa Osteoarthritis Pain Drugs Consumption Growth 2015-2020 (M Dose)
Figure 81. South Africa Osteoarthritis Pain Drugs Value Growth 2015-2020 ($ Millions)
Figure 82. Israel Osteoarthritis Pain Drugs Consumption Growth 2015-2020 (M Dose)
Figure 83. Israel Osteoarthritis Pain Drugs Value Growth 2015-2020 ($ Millions)
Figure 84. Turkey Osteoarthritis Pain Drugs Consumption Growth 2015-2020 (M Dose)
Figure 85. Turkey Osteoarthritis Pain Drugs Value Growth 2015-2020 ($ Millions)
Figure 86. GCC Countries Osteoarthritis Pain Drugs Consumption Growth 2015-2020 (M Dose)
Figure 87. GCC Countries Osteoarthritis Pain Drugs Value Growth 2015-2020 ($ Millions)
Figure 88. Global Osteoarthritis Pain Drugs Consumption Growth Rate Forecast (2021-2025) (M Dose)
Figure 89. Global Osteoarthritis Pain Drugs Value Growth Rate Forecast (2021-2025) ($ Millions)
Figure 90. Americas Osteoarthritis Pain Drugs Consumption 2021-2025 (M Dose)
Figure 91. Americas Osteoarthritis Pain Drugs Value 2021-2025 ($ Millions)
Figure 92. APAC Osteoarthritis Pain Drugs Consumption 2021-2025 (M Dose)
Figure 93. APAC Osteoarthritis Pain Drugs Value 2021-2025 ($ Millions)
Figure 94. Europe Osteoarthritis Pain Drugs Consumption 2021-2025 (M Dose)
Figure 95. Europe Osteoarthritis Pain Drugs Value 2021-2025 ($ Millions)
Figure 96. Middle East & Africa Osteoarthritis Pain Drugs Consumption 2021-2025 (M Dose)
Figure 97. Middle East & Africa Osteoarthritis Pain Drugs Value 2021-2025 ($ Millions)
Figure 98. United States Osteoarthritis Pain Drugs Consumption 2021-2025 (M Dose)
Figure 99. United States Osteoarthritis Pain Drugs Value 2021-2025 ($ Millions)
Figure 100. Canada Osteoarthritis Pain Drugs Consumption 2021-2025 (M Dose)
Figure 101. Canada Osteoarthritis Pain Drugs Value 2021-2025 ($ Millions)
Figure 102. Mexico Osteoarthritis Pain Drugs Consumption 2021-2025 (M Dose)
Figure 103. Mexico Osteoarthritis Pain Drugs Value 2021-2025 ($ Millions)
Figure 104. Brazil Osteoarthritis Pain Drugs Consumption 2021-2025 (M Dose)
Figure 105. Brazil Osteoarthritis Pain Drugs Value 2021-2025 ($ Millions)
Figure 106. China Osteoarthritis Pain Drugs Consumption 2021-2025 (M Dose)
Figure 107. China Osteoarthritis Pain Drugs Value 2021-2025 ($ Millions)
Figure 108. Japan Osteoarthritis Pain Drugs Consumption 2021-2025 (M Dose)
Figure 109. Japan Osteoarthritis Pain Drugs Value 2021-2025 ($ Millions)
Figure 110. Korea Osteoarthritis Pain Drugs Consumption 2021-2025 (M Dose)
Figure 111. Korea Osteoarthritis Pain Drugs Value 2021-2025 ($ Millions)
Figure 112. Southeast Asia Osteoarthritis Pain Drugs Consumption 2021-2025 (M Dose)
Figure 113. Southeast Asia Osteoarthritis Pain Drugs Value 2021-2025 ($ Millions)
Figure 114. India Osteoarthritis Pain Drugs Consumption 2021-2025 (M Dose)
Figure 115. India Osteoarthritis Pain Drugs Value 2021-2025 ($ Millions)
Figure 116. Australia Osteoarthritis Pain Drugs Consumption 2021-2025 (M Dose)
Figure 117. Australia Osteoarthritis Pain Drugs Value 2021-2025 ($ Millions)
Figure 118. Germany Osteoarthritis Pain Drugs Consumption 2021-2025 (M Dose)
Figure 119. Germany Osteoarthritis Pain Drugs Value 2021-2025 ($ Millions)
Figure 120. France Osteoarthritis Pain Drugs Consumption 2021-2025 (M Dose)
Figure 121. France Osteoarthritis Pain Drugs Value 2021-2025 ($ Millions)
Figure 122. UK Osteoarthritis Pain Drugs Consumption 2021-2025 (M Dose)
Figure 123. UK Osteoarthritis Pain Drugs Value 2021-2025 ($ Millions)
Figure 124. Italy Osteoarthritis Pain Drugs Consumption 2021-2025 (M Dose)
Figure 125. Italy Osteoarthritis Pain Drugs Value 2021-2025 ($ Millions)
Figure 126. Russia Osteoarthritis Pain Drugs Consumption 2021-2025 (M Dose)
Figure 127. Russia Osteoarthritis Pain Drugs Value 2021-2025 ($ Millions)
Figure 128. Spain Osteoarthritis Pain Drugs Consumption 2021-2025 (M Dose)
Figure 129. Spain Osteoarthritis Pain Drugs Value 2021-2025 ($ Millions)
Figure 130. Egypt Osteoarthritis Pain Drugs Consumption 2021-2025 (M Dose)
Figure 131. Egypt Osteoarthritis Pain Drugs Value 2021-2025 ($ Millions)
Figure 132. South Africa Osteoarthritis Pain Drugs Consumption 2021-2025 (M Dose)
Figure 133. South Africa Osteoarthritis Pain Drugs Value 2021-2025 ($ Millions)
Figure 134. Israel Osteoarthritis Pain Drugs Consumption 2021-2025 (M Dose)
Figure 135. Israel Osteoarthritis Pain Drugs Value 2021-2025 ($ Millions)
Figure 136. Turkey Osteoarthritis Pain Drugs Consumption 2021-2025 (M Dose)
Figure 137. Turkey Osteoarthritis Pain Drugs Value 2021-2025 ($ Millions)
Figure 138. GCC Countries Osteoarthritis Pain Drugs Consumption 2021-2025 (M Dose)
Figure 139. GCC Countries Osteoarthritis Pain Drugs Value 2021-2025 ($ Millions)
Figure 140. Sino Biopharmaceutical Osteoarthritis Pain Drugs Market Share (2018-2020)
Figure 141. Freda Osteoarthritis Pain Drugs Market Share (2018-2020)
Figure 142. Chugai Pharmaceutical Osteoarthritis Pain Drugs Market Share (2018-2020)
Figure 143. Mikasa Seiyaku Osteoarthritis Pain Drugs Market Share (2018-2020)
Figure 144. Bayer Osteoarthritis Pain Drugs Market Share (2018-2020)
Figure 145. Pfizer Osteoarthritis Pain Drugs Market Share (2018-2020)
Figure 146. Taisho Pharmaceutical Osteoarthritis Pain Drugs Market Share (2018-2020)
Figure 147. Haohai Biological Osteoarthritis Pain Drugs Market Share (2018-2020)
Figure 148. Zhejiang Chengyi Pharmaceutical Osteoarthritis Pain Drugs Market Share (2018-2020)
Figure 149. SK Chemicals Osteoarthritis Pain Drugs Market Share (2018-2020)
Figure 150. Crystal Genomics Osteoarthritis Pain Drugs Market Share (2018-2020)
Figure 151. GlaxoSmithKline Osteoarthritis Pain Drugs Market Share (2018-2020)
Figure 152. Johnson & Johnson Osteoarthritis Pain Drugs Market Share (2018-2020)
Figure 153. Bright Future Osteoarthritis Pain Drugs Market Share (2018-2020)
Figure 154. GSK Osteoarthritis Pain Drugs Market Share (2018-2020)
Figure 155. Seikagaku Corporation Osteoarthritis Pain Drugs Market Share (2018-2020)
Figure 156. Lilly Osteoarthritis Pain Drugs Market Share (2018-2020)
Figure 157. Sanofi Osteoarthritis Pain Drugs Market Share (2018-2020)
Figure 158. Jingfeng Pharmaceutical Osteoarthritis Pain Drugs Market Share (2018-2020)
Figure 159. Mylan Osteoarthritis Pain Drugs Market Share (2018-2020)
Figure 160. Almatica Pharma Osteoarthritis Pain Drugs Market Share (2018-2020)
Figure 161. TEVA Osteoarthritis Pain Drugs Market Share (2018-2020)
Figure 162. Abbott Laboratories Osteoarthritis Pain Drugs Market Share (2018-2020)
Figure 163. Iroko Pharmaceuticals Osteoarthritis Pain Drugs Market Share (2018-2020)
Please feel free to write an email to us or to use our electronic ticketing system.
